PE66798A1 - Analogos de la vitamina d3 tratados con fluor - Google Patents

Analogos de la vitamina d3 tratados con fluor

Info

Publication number
PE66798A1
PE66798A1 PE1997000387A PE00038797A PE66798A1 PE 66798 A1 PE66798 A1 PE 66798A1 PE 1997000387 A PE1997000387 A PE 1997000387A PE 00038797 A PE00038797 A PE 00038797A PE 66798 A1 PE66798 A1 PE 66798A1
Authority
PE
Peru
Prior art keywords
link
compounds
carbon
double
analogs
Prior art date
Application number
PE1997000387A
Other languages
English (en)
Inventor
Milan Radoje Uskokovic
Percy Sarwood Manchand
Jr John Joseph Nestor
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE66798A1 publication Critical patent/PE66798A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIEREN A COMPUESTOS DE FORMULA (I), EN DONDE: "X" ES =CH2 O SON HIDROGENO; R1 Y R2 SON DE PREFERENCIA H, CF3 O CH3, o R1 Y R2 JUNTO CON EL CARBONO 20 FORMAN UN CICLOFLUOROALQUILO O CICLOALQUILO C3-C6, o R1 Y R2 JUNTOS FORMAN =CH2; R3 Y R4 SON DE PREFERENCIA CH3, CF3, CH2CH3, CH2CF3, CF2CH3 Y CF2CF3 o R3 Y R4 JUNTO CON EL CARBONO 25 FORMAN UN CICLOFLUOROALQUILO O CICLOALQUILO C3-C9; "A" ES UN ENLACE SIMPLE O DOBLE; "B" ES UN ENLACE DOBLE O TRIPLE; SIEMPRE QUE: CUANDO "X" ES =CH2, "A" ES UN ENLACE DOBLE, Y: (i) R3 Y R4 SON CF3: SI UNO DE R1 Y R2 ES H, ENTONCES, EL OTRO NO ES CH3; (ii) R3 Y R4 SON ALQUILO C1-C2: SI R2 ES H, ENTONCES, R1 NO ES CH3; (iii) R3 Y R4 SON ALQUILO C1-C4: SI R1 ES H, ENTONCES, R2 NO ES CH3; (iv) R1 ES CH3, R2 ES H: SI UNO DE R3 Y R4 ES CF3, ENTONCES, EL OTRO NO ES CH3; (v) CUANDO "X" SEAN H, R3 Y R4 SON CF3, "A" ES UN ENLACE DOBLE, "B" ES UN ENLACE TRIPLE: SI R2 ES H, ENTONCES, R1 NO ES CH3. TAMBIEN SE REFIERE AL PROCEDIMIENTO DE PREPARACION DE LOS COMPUESTOS (I), QUE COMPRENDE ELIMINAR LOS GRUPOS PROTECTORES SILILO; Y A LOS COMPUESTOS INTERMEDIOS DE FORMULA (II), EN DONDE: R1 Y R2 SON CH3 o JUNTO CON EL CARBONO 20 FORMAN UN ANILLO CICLOPROPANO o FORMAN UN =CH2; R3, R4, "A" Y "B" SON COMO SE DEFINIERON PARA (I); "Y" ES H o OSi(CH3)3. LOS COMPUESTOS OBTENIDOS SON USADOS PARA TRATAR LA OSTEOPOROSIS
PE1997000387A 1996-05-23 1997-05-16 Analogos de la vitamina d3 tratados con fluor PE66798A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1821996P 1996-05-23 1996-05-23
US3990197P 1997-03-19 1997-03-19

Publications (1)

Publication Number Publication Date
PE66798A1 true PE66798A1 (es) 1998-10-22

Family

ID=26690870

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1997000387A PE66798A1 (es) 1996-05-23 1997-05-16 Analogos de la vitamina d3 tratados con fluor

Country Status (26)

Country Link
EP (1) EP0808832B1 (es)
JP (1) JP2859248B2 (es)
KR (1) KR100253961B1 (es)
CN (1) CN100402497C (es)
AR (1) AR007776A1 (es)
AT (1) ATE238278T1 (es)
AU (1) AU733970B2 (es)
BR (1) BR9703385A (es)
CA (1) CA2205315C (es)
CO (1) CO4940503A1 (es)
CZ (1) CZ157797A3 (es)
DE (1) DE69721123T2 (es)
DK (1) DK0808832T3 (es)
ES (1) ES2195049T3 (es)
HR (1) HRP970272A2 (es)
HU (1) HUP9700928A3 (es)
IL (1) IL120844A0 (es)
MA (1) MA24250A1 (es)
NO (1) NO972278L (es)
NZ (1) NZ314840A (es)
PE (1) PE66798A1 (es)
PL (1) PL320130A1 (es)
PT (1) PT808832E (es)
SG (1) SG70010A1 (es)
TR (1) TR199700416A2 (es)
YU (1) YU20097A (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008209A (en) * 1997-04-28 1999-12-28 Hoffmann-La Roche Inc. Method of using vitamin D3 analogs with bis C-20 side chains
DE19935771A1 (de) 1999-07-23 2001-02-01 Schering Ag Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
WO2002013832A1 (fr) * 2000-08-17 2002-02-21 Chugai Seiyaku Kabushiki Kaisha Agent therapeutique destine au traitement de l'osteoporose
CA2459789A1 (en) * 2001-09-21 2003-04-03 F. Hoffmann-La Roche Ag 3-desoxy-vitamin d3 analog esters
US7332482B2 (en) 2003-09-24 2008-02-19 Bioxell S.P.A. Method for treating benign prostatic hyperplasia
JP2008514621A (ja) * 2004-09-24 2008-05-08 ビオクセル エッセ ピ ア 20−シクロアルキル,26,27−アルキル/ハロアルキル−ビタミンd3化合物及びその使用方法
US20090099140A1 (en) * 2005-03-23 2009-04-16 Bioxell S.P.A. 20-Alkyl, Gemini Vitamin D3 Compounds and Methods of Use Thereof
BR112013009647A2 (pt) 2010-10-25 2016-07-12 Teijin Pharma Ltd derivado de vitamina, composição farmacêutica, agente terapêutico, e, composto

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4141746A1 (de) * 1991-12-13 1993-06-17 Schering Ag 20-methyl-substituierte vitamin d-derivate
DE4220757A1 (de) * 1992-06-24 1994-01-05 Schering Ag Derivate in der Vitamin D-Reihe mit Modifikationen in der 20-Position, Verfahren zu ihrer Herstellung, Zwischenprodukte für dieses Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US5384314B1 (en) * 1994-03-11 1997-08-05 Hoffmann La Roche 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
WO1997016193A1 (en) * 1995-10-27 1997-05-09 F. Hoffmann-La Roche Ag Pharmaceutical composition for treating osteoporosis

Also Published As

Publication number Publication date
YU20097A (sh) 1999-09-27
ATE238278T1 (de) 2003-05-15
NZ314840A (en) 1998-11-25
CA2205315C (en) 2006-10-24
BR9703385A (pt) 1998-09-15
EP0808832B1 (en) 2003-04-23
CZ157797A3 (en) 1997-12-17
EP0808832A3 (en) 1999-02-03
CO4940503A1 (es) 2000-07-24
HUP9700928A2 (hu) 1998-01-28
CN1172801A (zh) 1998-02-11
DE69721123D1 (de) 2003-05-28
JP2859248B2 (ja) 1999-02-17
MA24250A1 (fr) 1998-04-01
DE69721123T2 (de) 2004-01-08
AU733970B2 (en) 2001-05-31
DK0808832T3 (da) 2003-08-11
JPH1045714A (ja) 1998-02-17
NO972278L (no) 1997-11-24
EP0808832A2 (en) 1997-11-26
PT808832E (pt) 2003-07-31
IL120844A0 (en) 1997-09-30
NO972278D0 (no) 1997-05-20
PL320130A1 (en) 1997-11-24
TR199700416A2 (xx) 1997-12-21
ES2195049T3 (es) 2003-12-01
HUP9700928A3 (en) 1999-07-28
MX9703775A (es) 1998-06-30
CA2205315A1 (en) 1997-11-23
CN100402497C (zh) 2008-07-16
SG70010A1 (en) 2000-01-25
HRP970272A2 (en) 1998-04-30
KR970074764A (ko) 1997-12-10
AR007776A1 (es) 1999-11-24
HU9700928D0 (en) 1997-07-28
AU2357697A (en) 1997-11-27
KR100253961B1 (ko) 2000-04-15

Similar Documents

Publication Publication Date Title
CO4950531A1 (es) Analogos de la vitamina d3 composciiones farmaceuticas que los contienen
ES2055056T3 (es) Derivados de pirimidopirimidina.
ES2011210T3 (es) Derivados de gem-difosfonato substituido, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
MX9300031A (es) Derivados de piperazina, procedimiento para su preparacion y composicion farmaucetica que los contiene.
ES2045180T3 (es) Nuevo procedimiento para la obtencion de 4-aciloxi-3-hidroxietil-azetidinonas.
ES526318A0 (es) Procedimiento para la obtencion de derivados de 1-hidroxietil-triazolilo sustituidos
AR247402A1 (es) Un procedimiento para preparar antibioticos macrolidos c-20 aminosustituidos
PE66798A1 (es) Analogos de la vitamina d3 tratados con fluor
AR036000A1 (es) Proceso para la preparacion de derivados de indol y novedosos intermediarios
ES449096A1 (es) Un procedimiento para la preparacion de 11-desoxi-16-ariloxi-omega-tetranorprostaglandinas.
ES2145563T3 (es) Nuevos derivados de la imidazolina con una afinidad para los receptores imidazolinicos.
DK121383D0 (da) Fremgangsmade til fremstilling af 8-substituerede pyrrolizidinderivater
SE8003278L (sv) Fenyletylaminderivat
PT83452A (en) Process for preparing alkylmercaptaophenyl-1,3,4-oxa (or thia) iazole derivatives and nematicidal compositions therewith
SE9002596D0 (sv) A method for synthesis of prostaglandin derivatives
PA8475701A1 (es) Derivados de 3(2-oxo-[1,3']bipirrolidinil-3-ilidenmetil)-cephems
EA199900460A1 (ru) Производные бензолсульфоамида и лекарственные средства, содержащие упомянутые производные
AU583247B2 (en) Heteroaryloxypropanolamines
ES2032461T3 (es) Procedimiento para preparar derivados de indol.
ES2145905T3 (es) Procedimiento de produccion de acido 3-isoxazolcarboxilico.
ES520136A0 (es) Un procedimiento para la preparacion de un derivado del acido furiloxazolila-cetico
PE69199A1 (es) Derivados de arilsecocoladieno
ES2043605T3 (es) Procedimiento de preparacion de nuevos derivados del 4-morfolinil-1h-indol.
ES2169881T3 (es) Nuevos derivados de amida de pirrolidina sustituidos con heterociclo.
DK56285A (da) Carbacykliner, fremgangsmaade til fremstilling deraf, samt deres anvendelse som laegemidler

Legal Events

Date Code Title Description
FA Abandonment or withdrawal